These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 21726607)
1. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4. Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607 [TBL] [Abstract][Full Text] [Related]
2. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells. Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210 [TBL] [Abstract][Full Text] [Related]
3. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
4. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924 [TBL] [Abstract][Full Text] [Related]
5. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma. Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748 [TBL] [Abstract][Full Text] [Related]
6. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells. Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta1 decreases epithelial sodium channel functionality in renal collecting duct cells via a Smad4-dependent pathway. Chang CT; Hung CC; Chen YC; Yen TH; Wu MS; Yang CW; Phillips A; Tian YC Nephrol Dial Transplant; 2008 Apr; 23(4):1126-34. PubMed ID: 18045816 [TBL] [Abstract][Full Text] [Related]
8. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma. Kim SG; Song JY Oncol Rep; 2012 Aug; 28(2):539-44. PubMed ID: 22581233 [TBL] [Abstract][Full Text] [Related]
10. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma. Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018 [TBL] [Abstract][Full Text] [Related]
11. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck. Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor and transforming growth factor-beta1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Tian YC; Chen YC; Chang CT; Hung CC; Wu MS; Phillips A; Yang CW Exp Cell Res; 2007 Jul; 313(11):2367-77. PubMed ID: 17467690 [TBL] [Abstract][Full Text] [Related]
13. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD; Isayeva T; Siegal GP; Ponnazhagan S Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771 [TBL] [Abstract][Full Text] [Related]
14. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells. Park WH; Seol JG; Kim ES; Binderup L; Koeffler HP; Kim BK; Lee YY Int J Oncol; 2002 Mar; 20(3):533-42. PubMed ID: 11836565 [TBL] [Abstract][Full Text] [Related]
15. [Expression of secretory leukocyte proteinase inhibitor in human bronchial epithelial cell is downregulated by transforming growth factor-beta1/Smads pathway]. Niu RC; Luo BL; Hu CP; Feng JT Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2117-21. PubMed ID: 19080472 [TBL] [Abstract][Full Text] [Related]
16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
17. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655 [TBL] [Abstract][Full Text] [Related]
18. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line. He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247 [TBL] [Abstract][Full Text] [Related]
19. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas. Iglesias M; Frontelo P; Gamallo C; Quintanilla M Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574 [TBL] [Abstract][Full Text] [Related]
20. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y; Kyprianou N Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]